HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Subcutaneous granulocyte colony-stimulating factor administration for subacute traumatic spinal cord injuries, report of neurological and functional outcomes: a double-blind randomized controlled clinical trial.

Abstract
In BriefSpinal cord injury is among the most devastating neurological conditions affecting humans. The authors assessed the therapeutic efficacy of subcutaneous recombinant granulocyte colony-stimulating factor as an adjunct to classic surgical and rehabilitative treatments for subacute traumatic spinal cord injuries. This safe and noninvasive treatment may be helpful for better care and satisfaction of patients with this devastating condition throughout the world.
AuthorsNazi Derakhshanrad, Hooshang Saberi, Mir Saeed Yekaninejad, Mohammad Taghi Joghataei
JournalJournal of neurosurgery. Spine (J Neurosurg Spine) Vol. 30 Issue 1 Pg. 19-30 (10 12 2018) ISSN: 1547-5646 [Electronic] United States
PMID30497202 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References
  • Granulocyte Colony-Stimulating Factor
Topics
  • Adult
  • Double-Blind Method
  • Female
  • Granulocyte Colony-Stimulating Factor (therapeutic use)
  • Humans
  • Male
  • Recovery of Function (drug effects)
  • Spinal Cord Injuries (drug therapy, rehabilitation)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: